HF Risk Elevated Among Young Adult Cancer Survivors
This is the first study to investigate a potential connection between anthracycline chemotherapy and risk of heart failure (HF) in young adult cancer survivors.
Related Articles
Emerging Therapeutic Areas for Bispecific Antibodies
Experts discuss the most promising applications of bispecifics in solid tumors and other emerging therapeutic areas.
FDA-Approved and Pipeline Treatments for Elevated Lp(a) Levels
Experts discuss FDA-approved therapies for high lipoprotein(a) [Lp[a]) levels, their benefits and shortcomings, the frequency of their use in health plans, emerging therapies in the…
New Tools Aim to Close Lung Cancer Screening Gap: Raymond Osarogiagbon, MD
Raymond Osarogiagbon, MD, discusses innovative strategies for improving lung cancer screening, including artificial intelligence (AI) tools and simplified eligibility criteria.
Introduction of ECAPS Act Prompts Nationwide Call to Action From Pharmacists Aimed at Congress
The Ensuring Community Access to Pharmacist Services (ECAPS) Act of 2025 (H.R. 3164) aims to ensure vital pharmacy services and access to care for underserved…
Bipartisan Bill Aims to Slash Drug Prices by Tying Costs to International Averages
The goal of the proposed bill is to “make prescriptions affordable again” in the US.
Updated Guidelines Aim to Improve GERD Diagnosis and Treatment
The American Society for Gastrointestinal Endoscopy has issued new guidelines for diagnosing and managing gastroesophageal reflux disease (GERD), with updated recommendations on endoscopy use, lifestyle…
Telepsychiatry Services Cut Hospitalization Rates Without Raising Overall Costs
Timely outpatient telepsychiatry care for Medicaid enrollees was associated with lower hospitalization rates and comparable overall costs, supporting its potential role in value-based care models.
Economic Burden Associated With Uncomplicated UTIs
Panelists discuss how treatment failure in uncomplicated urinary tract infections (UTIs) creates substantial economic burden through direct costs of additional health care visits, repeated diagnostic…
Expanding Access to CGTs Through Innovative Payment Models: Joe DePinto, MBA
Innovative financing and reimbursement models can improve access to cell and gene therapies, addressing cost barriers and improving patient outcomes, said Joe DePinto, MBA, of…
Reinventing Oncology: The Urgent Need to Address Access, Burnout, and Adherence in a Shifting Landscape
The American Journal of Managed Care provides insights into the latest news and research in managed care across multimedia platforms.